Les Laboratoires Bio ForeXtra Inc. – Trademark Portfolio
Entity Type: 03
Les Laboratoires Bio ForeXtra Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BOREALINE. The owner is based in Québec.
Place de la cite, Tour Belle Cour, 2950,
Boul. Laurier, bureau 650
Québec G1V4M6 , CA
Showing of trademarks Trademarks
Trademark Classifications
Les Laboratoires Bio ForeXtra Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Les Laboratoires Bio ForeXtra Inc. have?
Les Laboratoires Bio ForeXtra Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Les Laboratoires Bio ForeXtra Inc. file in?
Les Laboratoires Bio ForeXtra Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Les Laboratoires Bio ForeXtra Inc.'s most well-known trademarks?
Les Laboratoires Bio ForeXtra Inc.'s registered trademark portfolio includes well-known marks such as BOREALINE. These are among 1 currently registered trademark in the portfolio.
What is Les Laboratoires Bio ForeXtra Inc.'s trademark registration success rate?
Les Laboratoires Bio ForeXtra Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.